STOCK TITAN

[8-K] LAM RESEARCH CORP Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Lam Research Corporation furnished an Item 2.02 Form 8‑K stating it issued a press release announcing financial results for the fiscal quarter ended September 28, 2025.

The press release is attached as Exhibit 99.1 and, along with Item 2.02, is furnished and not deemed filed under the Exchange Act, nor incorporated by reference. The filing notes the Company’s common stock (LRCX) is listed on the Nasdaq Global Select Market.

Lam Research Corporation ha fornito un modulo 8-K Item 2.02 in cui si comunica che è stato emesso un comunicato stampa contenente i risultati finanziari per il trimestre fiscale conclusosi il 28 settembre 2025.

Il comunicato stampa è allegato come Allegato 99.1 e, insieme all'Item 2.02, è fornito e non considerato depositato ai sensi della Exchange Act, né incorporato per riferimento. Il deposito segnala che le azioni ordinarie della Società (LRCX) sono quotate sul Nasdaq Global Select Market.

La Lam Research Corporation presentó un Formulario 8-K de la Sección 2.02, indicando que se emitió un comunicado de prensa anunciando los resultados financieros del trimestre fiscal terminado el 28 de septiembre de 2025.

El comunicado de prensa está adjunto como el Exhibit 99.1 y, junto con la Sección 2.02, se proporciona y no se considera presentado conforme a la Ley de Intercambio, ni incorporado por referencia. El expediente señala que las acciones comunes de la Compañía (LRCX) están cotizadas en Nasdaq Global Select Market.

Lam Research Corporation은 제2조.02 양식 8-K를 제출했으며, 2025년 9월 28일에 종료된 회계 분기에 대한 재무 실적 발표 보도자료를 발표했다고 공시했습니다.

보도자료는 Exhibit 99.1로 첨부되어 있으며, 제2조.02와 함께 Exchange Act에 따라 제출된 것으로 간주되지 않으며 참조에 의한 통합도 되지 않습니다. 제출 문서는 회사의 보통주(LRCX)가 Nasdaq Global Select Market에 상장되어 있음을 명시합니다.

Lam Research Corporation a fourni un formulaire 8-K, section 2.02, indiquant qu'il a publié un communiqué de presse annonçant les résultats financiers du trimestre fiscal ayant pris fin le 28 septembre 2025.

Le communiqué de presse est joint en tant que Exhibit 99.1 et, avec l'Item 2.02, est fourni et n'est pas considéré comme déposé en vertu de la loi sur les changes, ni incorporé par référence. Le dossier indique que les actions ordinaires de la société (LRCX) sont cotées sur le Nasdaq Global Select Market.

Lam Research Corporation legte ein Item 2.02 Form 8-K vor, in dem bekannt gegeben wird, dass eine Pressemitteilung zu den Finanzergebnissen für das am 28. September 2025 endende Geschäftsjahr veröffentlicht wurde.

Die Pressemitteilung ist als Exhibit 99.1 beigefügt und zusammen mit Item 2.02 wird sie bereitgestellt und gilt weder als eingereicht nach dem Exchange Act noch als durch Verweis integriert. Die Einreichung vermerkt, dass die Stammaktien des Unternehmens (LRCX) an der Nasdaq Global Select Market notiert sind.

قدمت شركة Lam Research Corporation نموذج 8-K للمادة 2.02 تفيد بأنها أصدرت بياناً صحفياً يعلن عن النتائج المالية للربع المالي المنتهي في 28 سبتمبر 2025.

البيان الصحفي مرفق كمعروض 99.1، وبالإضافة إلى المادة 2.02، فهو مقدم وليس مسجلاً بموجب قانون التداول، ولا يُدرج بالمرجع. يشير الملف إلى أن أسهم الشركة العادية (LRCX) مُدرجة في Nasdaq Global Select Market.

Lam Research Corporation 提交了 Item 2.02 的 Form 8-K,声明发布了一份新闻稿,宣布截至 2025 年 9 月 28 日的财政季度财务业绩。

新闻稿作为 Exhibit 99.1 附件,与 Item 2.02 一并提交,且不视为按《交易法》备案,也不通过引用纳入。本次备案注明公司普通股(LRCX)在纳斯达克全球精选市场上市。

Positive
  • None.
Negative
  • None.

Lam Research Corporation ha fornito un modulo 8-K Item 2.02 in cui si comunica che è stato emesso un comunicato stampa contenente i risultati finanziari per il trimestre fiscale conclusosi il 28 settembre 2025.

Il comunicato stampa è allegato come Allegato 99.1 e, insieme all'Item 2.02, è fornito e non considerato depositato ai sensi della Exchange Act, né incorporato per riferimento. Il deposito segnala che le azioni ordinarie della Società (LRCX) sono quotate sul Nasdaq Global Select Market.

La Lam Research Corporation presentó un Formulario 8-K de la Sección 2.02, indicando que se emitió un comunicado de prensa anunciando los resultados financieros del trimestre fiscal terminado el 28 de septiembre de 2025.

El comunicado de prensa está adjunto como el Exhibit 99.1 y, junto con la Sección 2.02, se proporciona y no se considera presentado conforme a la Ley de Intercambio, ni incorporado por referencia. El expediente señala que las acciones comunes de la Compañía (LRCX) están cotizadas en Nasdaq Global Select Market.

Lam Research Corporation은 제2조.02 양식 8-K를 제출했으며, 2025년 9월 28일에 종료된 회계 분기에 대한 재무 실적 발표 보도자료를 발표했다고 공시했습니다.

보도자료는 Exhibit 99.1로 첨부되어 있으며, 제2조.02와 함께 Exchange Act에 따라 제출된 것으로 간주되지 않으며 참조에 의한 통합도 되지 않습니다. 제출 문서는 회사의 보통주(LRCX)가 Nasdaq Global Select Market에 상장되어 있음을 명시합니다.

Lam Research Corporation a fourni un formulaire 8-K, section 2.02, indiquant qu'il a publié un communiqué de presse annonçant les résultats financiers du trimestre fiscal ayant pris fin le 28 septembre 2025.

Le communiqué de presse est joint en tant que Exhibit 99.1 et, avec l'Item 2.02, est fourni et n'est pas considéré comme déposé en vertu de la loi sur les changes, ni incorporé par référence. Le dossier indique que les actions ordinaires de la société (LRCX) sont cotées sur le Nasdaq Global Select Market.

Lam Research Corporation legte ein Item 2.02 Form 8-K vor, in dem bekannt gegeben wird, dass eine Pressemitteilung zu den Finanzergebnissen für das am 28. September 2025 endende Geschäftsjahr veröffentlicht wurde.

Die Pressemitteilung ist als Exhibit 99.1 beigefügt und zusammen mit Item 2.02 wird sie bereitgestellt und gilt weder als eingereicht nach dem Exchange Act noch als durch Verweis integriert. Die Einreichung vermerkt, dass die Stammaktien des Unternehmens (LRCX) an der Nasdaq Global Select Market notiert sind.

false000070754900007075492025-10-222025-10-22
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 22, 2025
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 0-12933 94-2634797
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareLRCXThe Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                     


Table of Contents
Table of Contents
 
Item 2.02.  Results of Operations and Financial Condition 
3
Item 9.01.  Financial Statements and Exhibits 
3
SIGNATURES 
4
EX-99.1


Table of Contents
 Item 2.02.Results of Operations and Financial Condition
On October 22, 2025, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 28, 2025, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01.Financial Statements and Exhibits
(d) Exhibits
99.1
Press Release dated October 22, 2025 announcing financial results for the fiscal quarter ended September 28, 2025
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document


Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:October 22, 2025
LAM RESEARCH CORPORATION
(Registrant)
 /s/ Douglas R. Bettinger
 Douglas R. Bettinger
 Executive Vice President and Chief Financial Officer
 (Principal Financial Officer)
 


FAQ

What did Lam Research (LRCX) disclose in this 8‑K?

It furnished an Item 2.02 report stating it issued a press release announcing financial results for the fiscal quarter ended September 28, 2025.

Which period does the Lam Research (LRCX) press release cover?

The fiscal quarter ended September 28, 2025.

How is the information in the 8‑K treated under the Exchange Act?

The Item 2.02 information, including Exhibit 99.1, is furnished and not deemed filed or incorporated by reference.

Where can I find the detailed results referenced by Lam Research (LRCX)?

In Exhibit 99.1, the press release announcing the quarter’s financial results.

What is Lam Research’s trading symbol and listing venue?

The common stock trades as LRCX on the Nasdaq Global Select Market.

Who signed the 8‑K for Lam Research?

Douglas R. Bettinger, Executive Vice President and Chief Financial Officer (Principal Financial Officer).

What is the date of the report for this Lam Research (LRCX) 8‑K?

October 22, 2025.

Lam Research

NASDAQ:LRCX

LRCX Rankings

LRCX Latest News

LRCX Latest SEC Filings

LRCX Stock Data

182.90B
1.26B
0.29%
89%
2.5%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
FREMONT